Tags

Type your tag names separated by a space and hit enter

Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China.
Hum Vaccin Immunother. 2023 12 31; 19(1):2158012.HV

Abstract

This study aimed to determine the willingness of college students to choose COVID-19 heterologous vaccination and its associated influencing factors in Taizhou, China. A population-based, self-administered online questionnaire was conducted from March 15 to 17, 2022. Of the 2,463 participants who had received the invitation, 1,821 responded to the survey (response rate = 73.9%). Only 14% (86/614) of those willing to receive a booster would chose a heterologous vaccination; the perception of better effectiveness of a COVID-19 heterologous vaccination booster was the significant factor (X2 = 22.671, p < .001). Additionally, female college students'older age (χ2 = 7.523, P = .023), major of medical (χ2 = 6.294, P = .012), and better perceived effectiveness of COVID-19 heterologous vaccination booster (χ2 = 22.659, P < .001), were more willing to receive heterologous booster doses. Chinese college students have a strong willingness to receive booster shots, but the percentage of those willing to receive a heterologous vaccine is only 14.0%, and the lack of understanding of its effectiveness is an important factor in the low proportion of heterologous vaccine selection. Health education, public health awareness, and the disclosure of heterologous vaccine information can help improve the public's understanding of heterologous vaccines and provide them with more choices.

Links

Authors+Show Affiliations

Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.

Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.

Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.

Department of Infectious Diseases, Taizhou Hospital, Zhejiang University, Linhai, Zhejiang, China.

Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.

Evidence-based Medicine Center, Taizhou Hospital of Zhejiang Province, Wenzhou, Medical University, Wenzhou, Linhai, Zhejiang, China.

Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.

MeSH

FemaleHumansAsian PeopleChinaCOVID-19StudentsVaccinationCOVID-19 Vaccines

Pub Type(s)

Journal Article

Language

eng

PubMed ID

36606519

Citation

Shao, Hui, et al. "Willingness of College Students to Receive COVID-19 Heterologous Vaccination in Taizhou, China." Human Vaccines & Immunotherapeutics, vol. 19, no. 1, 2023, p. 2158012.

Shao H, Lin XQ, Chen Y, et al. Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China. Hum Vaccin Immunother. 2023;19(1):2158012.

Shao, H., Lin, X. Q., Chen, Y., Lv, L., Ying, C. Q., Tung, T. H., & Zhu, J. S. (2023). Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China. Human Vaccines & Immunotherapeutics, 19(1), 2158012. https://doi.org/10.1080/21645515.2022.2158012

Shao H, et al. Willingness of College Students to Receive COVID-19 Heterologous Vaccination in Taizhou, China. Hum Vaccin Immunother. 2023 12 31;19(1):2158012. PubMed PMID: 36606519.

* Article titles in AMA citation format should be in sentence-case

TY - JOUR T1 - Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China. AU - Shao,Hui, AU - Lin,Xiao-Qing, AU - Chen,Yan, AU - Lv,Li, AU - Ying,Chen-Qian, AU - Tung,Tao-Hsin, AU - Zhu,Jian-Sheng, Y1 - 2023/01/06/ PY - 2023/1/7/pubmed PY - 2023/2/18/medline PY - 2023/1/6/entrez KW - COVID-19 KW - Heterologous vaccination KW - booster KW - college students KW - willingness SP - 2158012 EP - 2158012 JF - Human vaccines & immunotherapeutics JO - Hum Vaccin Immunother VL - 19 IS - 1 N2 - This study aimed to determine the willingness of college students to choose COVID-19 heterologous vaccination and its associated influencing factors in Taizhou, China. A population-based, self-administered online questionnaire was conducted from March 15 to 17, 2022. Of the 2,463 participants who had received the invitation, 1,821 responded to the survey (response rate = 73.9%). Only 14% (86/614) of those willing to receive a booster would chose a heterologous vaccination; the perception of better effectiveness of a COVID-19 heterologous vaccination booster was the significant factor (X2 = 22.671, p < .001). Additionally, female college students'older age (χ2 = 7.523, P = .023), major of medical (χ2 = 6.294, P = .012), and better perceived effectiveness of COVID-19 heterologous vaccination booster (χ2 = 22.659, P < .001), were more willing to receive heterologous booster doses. Chinese college students have a strong willingness to receive booster shots, but the percentage of those willing to receive a heterologous vaccine is only 14.0%, and the lack of understanding of its effectiveness is an important factor in the low proportion of heterologous vaccine selection. Health education, public health awareness, and the disclosure of heterologous vaccine information can help improve the public's understanding of heterologous vaccines and provide them with more choices. SN - 2164-554X UR - https://www.unboundmedicine.com/medline/citation/36606519/Willingness_of_college_students_to_receive_COVID_19_heterologous_vaccination_in_Taizhou_China_ DB - PRIME DP - Unbound Medicine ER -